North Carolina
- 4 patients
- Onset: October
- Results of specimens for resistance to antiviral came back approx. 11/7.
- In hospital at time of becoming infected
- All were severely ill at time of infection
- In same ward of hospital housing patients with cancer or severe blood disorders
- 3 of the 4 died.
- 4th is extremely ill, treating with Relenza, appears to be recovering
- Investigation launched w/CDC (3 Epidemic Intelligance Svc.) to determine whether Tamiflu-resistance flu is circulating elsewhere in NC.
--Testing virus samples to see whether they are identical.
Wales
- 5 people confirmed with Tamiflu resistance
- In hospital at time of becoming infected
- All were severely ill at time of infection
- In same ward of hospital housing patients with severe illnesses
- 2 have recovered and discharged
- 1 in critical care
- 2 still being treated
- 4 others infected (“with same genetic mutation” Health Protection Agency)
- 1 of these were helped with Tamiflu
- 3 others it is not clear.
- Same ward as the 5 confirmed Tamiflu resistance
As a side-note...I was reminded of the new addition to the vaccines. GlaxoSmithKline. In the Package Insert, it states this:
” Immunosuppressive therapies may reduce immune responses to Influenza A (H1N1) 2009 Monovalent Vaccine. (7.2)”....and this:
“Immunocompromised persons may have a reduced immune response to Influenza A (H1N1) 2009 Monovalent Vaccine. (5.2)”
Post located here: http://pandemicinformationnews.blogspot.com/2009/11/additional-information-on-latest-new.html
No comments:
Post a Comment